NDC 63653-1171

Plavix

Clopidogrel

Plavix is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bristol-myers Squibb/sanofi Pharmaceuticals Partnership. The primary component is Clopidogrel Bisulfate.

• Product ID: 63653-1171_12eb3088-f30b-4bb5-aee0-113114b5a08c
• NDC: 63653-1171
• Product Type: Human Prescription Drug
• Proprietary Name: Plavix
• Generic Name: Clopidogrel
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 1997-11-17
• Marketing End Date: 2022-07-31
• Marketing Category: NDA / NDA
• Application Number: NDA020839
• Labeler Name: Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
• Substance Name: CLOPIDOGREL BISULFATE
• Active Ingredient Strength: 75 mg/1
• Pharm Classes: Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
• NDC Exclude Flag: N

Packaging

NDC 63653-1171-1

90 TABLET, FILM COATED in 1 BOTTLE (63653-1171-1)

• Marketing Start Date: 1997-11-17
• Marketing End Date: 2022-07-31
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63653-1171-6 [63653117106]

Plavix TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA020839
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1997-11-17

NDC 63653-1171-1 [63653117101]

Plavix TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA020839
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1997-11-17

NDC 63653-1171-3 [63653117103]

Plavix TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA020839
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1997-11-17
• Marketing End Date: 2020-05-31

NDC 63653-1171-5 [63653117105]

Plavix TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA020839
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1997-11-17
• Marketing End Date: 2020-06-30

Drug Details

Active Ingredients

Ingredient	Strength
CLOPIDOGREL BISULFATE	75 mg/1

OpenFDA Data

• SPL SET ID: 01b14603-8f29-4fa3-8d7e-9d523f802e0b
• Manufacturer:
  • Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
• UNII:
  • 08I79HTP27
• RxNorm Concept Unique ID - RxCUI:
  • 213169
  • 749196
  • 749198
  • 309362

Pharmacological Class

• Decreased Platelet Aggregation [PE]
• P2Y12 Platelet Inhibitor [EPC]
• P2Y12 Receptor Antagonists [MoA]
• Cytochrome P450 2C8 Inhibitors [MoA]

Medicade Reported Pricing

63653117106 PLAVIX 75 MG TABLET

Pricing Unit: EA | Drug Type:

63653117105 PLAVIX 75 MG TABLET

Pricing Unit: EA | Drug Type:

63653117103 PLAVIX 75 MG TABLET

Pricing Unit: EA | Drug Type:

63653117101 PLAVIX 75 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Plavix" or generic name "Clopidogrel"

NDC	Brand Name	Generic Name
0024-1171	Plavix	clopidogrel
0024-1332	Plavix	clopidogrel
21695-665	Plavix	clopidogrel bisulfate
53808-0763	Plavix	Plavix
55289-911	Plavix	Plavix
63653-1332	Plavix	Plavix
63653-1171	Plavix	Plavix
67046-604	Plavix	Plavix
0093-7314	Clopidogrel	Clopidogrel
0615-7719	Clopidogrel	Clopidogrel
16714-052	Clopidogrel	Clopidogrel
16729-218	Clopidogrel	Clopidogrel
16729-219	Clopidogrel	Clopidogrel
31722-901	clopidogrel	clopidogrel
31722-902	clopidogrel	clopidogrel
33342-060	Clopidogrel	Clopidogrel
42543-713	Clopidogrel	clopidogrel
42543-714	Clopidogrel	clopidogrel
43547-484	CLOPIDOGREL	clopidogrel
43547-485	CLOPIDOGREL	clopidogrel
50090-4918	Clopidogrel	Clopidogrel
50090-5781	Clopidogrel	Clopidogrel
52605-082	clopidogrel	clopidogrel
0378-3627	Clopidogrel Bisulfate	clopidogrel
51079-558	Clopidogrel Bisulfate	clopidogrel